Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Grommes

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
JCO Oncology Practice|June 25, 2024
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS LymphomaLauren R Schaff, Dean Carlow, Ryan Schofield, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2024
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System LymphomaKathryn R Tringale, Christian Grommes, Burcin A Ucpinar, et al.
Neuro-Oncology Practice|December 29, 2025
Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residentsElizabeth C Neil, Aubree Bruhnding, Zubair A Ahmed, et al.
Blood|September 29, 2018
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphomaHan W Tun, Patrick B Johnston, Lisa M DeAngelis, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal FluidElena I Pentsova, Ronak H Shah, Jiabin Tang, et al.
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
JCO Oncology Practice|June 25, 2024
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS LymphomaLauren R Schaff, Dean Carlow, Ryan Schofield, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2024
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System LymphomaKathryn R Tringale, Christian Grommes, Burcin A Ucpinar, et al.
Neuro-Oncology Practice|December 29, 2025
Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residentsElizabeth C Neil, Aubree Bruhnding, Zubair A Ahmed, et al.
Blood|September 29, 2018
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphomaHan W Tun, Patrick B Johnston, Lisa M DeAngelis, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal FluidElena I Pentsova, Ronak H Shah, Jiabin Tang, et al.
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
Pageof 10